Linked Life Data

6978586

Source:http://linkedlifedata.com/resource/pubmed/id/6978586

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1982-6-14
pubmed:abstractText
The effect of Levamisol administered to patients with trichinosis, the influence thereof on the behaviour of lymphocytes T and B in the peripheral blood as well as the clinical course of the disease were analysed. In the 4th week Levamisol was administered to the patients in doses of 150 mg/24 h for 3 days and the same dose was given for 7 days in the 2nd and 4th week of the disease. The control group included patients with trichinosis who had not been given any drugs to produce immunological processes. A slight decrease in the percentage of T lymphocytes in the peripheral blood was observed in patients who had received Levamisol, immediately after having begun treatment. An increase in the percentage of T lymphocytes was noted in the patients who were treated with the drug as early as in the 2nd week of the disease. In patients treated with Levamisol, subjective complaints were observed which, however, ceased soon afterwards. No side effects of the drug were found.
pubmed:language
ger
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0174-3031
pubmed:author
pubmed:issnType
Print
pubmed:volume
251
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
273-8
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed:year
1981
pubmed:articleTitle
[Immunomodulating action of levamisol preparation in the treatment of trichinellosis (author's transl)].
pubmed:publicationType
Journal Article, English Abstract